Find verified buyers and importers for
Pharmaceutical formulations
India exported $21.9 billion of Pharmaceutical formulations (HS 3004) in FY25-26 (DGFT). The top export markets are USA, UK, UAE, GERMANY, SAUDI-ARABIA. HS 3004 covers medicaments in measured doses for therapeutic or prophylactic use. India is the world's third-largest pharma exporter by volume and supplies over 20% of global generics. Hyderabad-Telangana and Gujarat lead formulation exports. diipl turns this market intelligence into verified buyers for your product, matched to your capacity and verified before you meet, not a data list. Pick a market below for its import duty, NTM requirements, and buyer-discovery breakdown.
Looking to find buyers for your pharmaceutical formulations?
See the Pharmaceutical Formulations buyer pageFind Pharmaceutical formulations buyers by country
Each page shows import duty, NTM requirements, Indian clusters sourcing this HS code, and a step-by-step buyer-discovery guide.
Buyers for Pharmaceutical formulations · HS 3004
Buyers for Pharmaceutical formulations · HS 3004
Buyers for Pharmaceutical formulations · HS 3004
Buyers for Pharmaceutical formulations · HS 3004
Buyers for Pharmaceutical formulations · HS 3004
Top Indian manufacturing clusters for HS 3004
Indicative cluster mapping. Data current as of FY25-26 unless otherwise noted.
Common certifications for HS 3004 exports
Certification requirements vary by destination market and sub-heading. Verify current requirements with DGFT, relevant EPCs, and the destination country's import authority before shipment.
Want a full market analysis for HS 3004?
diipl's free Market Research Report covers tariff corridors, top importers, CAGR, price benchmarks, and a recommended entry strategy.